[1]Zhang,Wen;Sviripa,VitaliyM.;Kril,LiliiaM.;Yu,Tianxin;Xie,Yanqi;Hubbard,W.Brad;Sullivan,PatrickG.;Chen,Xi;Zhan,Chang-Guo;Yang-Hartwich,Yang;Evers,B.Mark;Spear,BrettT.;Gedaly,Roberto;Watt,DavidS.;Liu,Chunming[JournalofMedicinalChemistry,2019,vol.62,#24,p.11348-11358]
[2]CurrentPatentAssignee:YALEUNIVERSITY;UNIVERSITYOFKENTUCKY-WO2020/168290,2020,A1Locationinpatent:Paragraph0104
Title: Inhibitory Effects of Bisphenol-A on Neural Stem Cells Proliferation and Differentiation in the Rat Brain Are Dependent on Wnt/β-Catenin Pathway.
Journal: Molecular neurobiology 20151201
Title: Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression.
Journal: Toxicology 20141105
Title: IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Journal: Journal of cellular biochemistry 20121101
Title: Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling.
Journal: Toxicology and applied pharmacology 20121015
Title: Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
Journal: International journal of biological sciences 20120101
Title: FH535 potentiation of cigarette smoke condensate cytotoxicity is associated with changes in β-catenin and EGR-1 signaling.
Journal: International journal of toxicology 20120101
Title: A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
Journal: Molecular cancer therapeutics 20080301
Title: Handeli S, et al. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol Cancer Ther. 2008 Mar;7(3):521-9.
Title: Wu MY, et al. FH535 inhibited metastasis and growth of pancreatic cancer cells. Onco Targets Ther. 2015 Jul 6;8:1651-70.
Title: Liu L, et al. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget. 2016 Jul 26;7(30):47145-47162.
